ICM
MACK

Indaba Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Indaba Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-223,459
Closed -$3M – 9
2023
Q4 		$3M Buy
223,459
+86,657
+63% +$1.16M 1.72% 7
2023
Q3 		$1.69M Buy
+136,802
New +$1.69M 0.5% 10